Haemonetics (HAE) PT Raised to $142 at Baird

October 15, 2026 7:22 AM

Baird analyst David Rescott raised the price target on Haemonetics (NYSE: HAE) to $142.00 (from $119.00) while maintaining a Outperform rating.

No results found